Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Name: Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
Published: 2026
License: Public Domain

Actinium Pharmaceuticals · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

acute acutemyeloidleukemia leukemia

acute leukemia, myeloid leukemia, acute myelogenous leukemia, acute myeloid leukemia, acute myeloid leukemia, in relapse, myelogenous leukemia, myelogenous leukemia, acute, myelogenous leukemia in relapse, transplant-related disorder, allogeneic disease, refractory aml, leukemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 849442
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.